| Literature DB >> 862378 |
P Schuster, E Gabriel, B Küfferle, G Strobl, M Karobath.
Abstract
Clozapine, a new antipsychotic drug without extrapyramidal side effects and with strong sedating potency, can produce acute symptoms of central anticholinergic toxicity. The authors report that physostigmine, a reversible anticholinesterase agent, which can pass the blood-brain barrier, was effective in reversing the clozapine-induced brain syndrome in two patients. Physostigmine also reduced one patient's tachycardia.Entities:
Mesh:
Substances:
Year: 1977 PMID: 862378 DOI: 10.3109/15563657709046281
Source DB: PubMed Journal: Clin Toxicol ISSN: 0009-9309 Impact factor: 4.467